Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients

Pathology Research and Practice

Volumn 197, Issue 2, 2001, Pages 77-84

  Thiele, J ^a,b   Kvasnicka, H M ^a   Muehlhausen, K ^a   Walter, S ^a   Zankovich, R ^b   Diehl, V ^b  

^a Institute of Pathology   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Bone marrow biopsies; Clinical findings; Histopathology; Polycythemia vera; Secondary polycythemia

Indexed keywords

ALKALINE PHOSPHATASE; ERYTHROPOIETIN; HEMOGLOBIN; IRON; LACTATE DEHYDROGENASE; RETICULIN;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CELL NUCLEUS; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROCYTOSIS; EVALUATION; FEMALE; HEMATOPOIESIS; HEMOGLOBIN DETERMINATION; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LEUKOCYTE COUNT; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MEGAKARYOPOIESIS; PLASMACYTOSIS; POLYCYTHEMIA VERA; RETICULUM CELL; SPLEEN SIZE; THROMBOCYTE COUNT;

EID: 0035115281     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-5710013     Document Type: Article

References (40)

1. Pathogenesis of polycythemia vera: Do we have the right pieces to this puzzle?
2. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD)
3. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group Protocols
4. Diagnosis and classification of the polycythemias
5. Polycythemia rubra vera
6. Chronic myeloproliferative disorders (CMPD)
7. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
8. Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes
9. Hematopathologic findings in the myeloproliferative disorders
10. The bone marrow in polycythemia vera
11. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies
12. Patterns of in vitro BFU-E proliferation in different forms of polycythaemia and in thrombocythaemia
13. The immunohistological detection of platelet, megakaryocytes and thrombi in routinely processed specimens
14. Chronic myeloproliferative disorders in bone marrow biopsies
15. Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies
16. The histopathology of chronic myeloproliferative diseases
17. Polycythemia: Mechanisms and management
18. The present state of pathophysiology and therapeutic trials in polycythemia vera
19. Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis
20. Megakaryocytes in chronic myeloproliferative disorders: Numerical density correlated between different entities
21. A prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia
22. Diagnosis of polycythemia
23. Low serum erythropoietin - A strong diagnostic criterion of primary polycythaemia even at normal haemoglobin levels
24. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group
25. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG
26. Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia
27. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders
28. Radioimmunoassay of immunoreactive erythropoietin as a clinical tool for the classification of polycythaemias
29. Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years
30. Spontaneous erythroid colony formation in the differential diagnosis of erythrocytosis
31. Diagnosis and classification of erythrocytoses and thrombocytoses
32. The diagnostic criteria of polycythaemia rubra vera
33. The bone marrow in polycythemia vera
34. How to fix, decalcify and stain paraffin embedded bone marrow biopsies
35. Interferon alfa: Effects of long-term treatment for polycythemia vera
36. Proliferation cell nuclear antigen expression by erythroid precursors in normal bone marrow, in reactive lesions and in polycythaemia rubra vera
37. Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies
38. Primary (essential) thrombocythemia versus polycythemia vera rubra. A histomorphometric analysis of bone marrow features in trephine biopsies
39. Polycythemia vera. I. Histopathology, ultrastructure and cytogenetics of the bone marrow in comparison with secondary polycythemia
40. Primary polycythaemia: Diagnosis by non-conventional positive criteria